Close

Canaccord Genuity Maintains a 'Buy' on ZIOPHARM Oncology (ZIOP); Q3/11 Update Nov 10, 2011 09:00AM
Canaccord Genuity Maintains a 'Buy' on ZIOPHARM Oncology (ZIOP); Q2/11 Update Aug 2, 2011 08:42AM
Canaccord Genuity Maintains a 'Buy' on ZIOPHARM Oncology (ZIOP); Model Updates Following Q1/11 Results May 10, 2011 11:17AM
Notable Analyst Rating Changes 02/09: UBS, BIDU, NYX, AN Upgraded; KEY, CMS, ILMN, JOE Downgraded Feb 9, 2011 10:54AM
Canaccord Genuity on Life Sciences/Biotechnology: Selected Small Cap Biotech Roundup Dec 28, 2010 09:35AM


Nov 30, 2010 10:54AM Canaccord Genuity Reiterates a 'Buy' on ZIOPHARM Oncology (ZIOP); Diversified Oncology Pipeline Highlighted at R&D Event
Aug 25, 2010 12:12PM Canaccord Genuity Rates ZIOPHARM (ZIOP) a New 'Buy', Positive On Palifosfamide